Literature DB >> 2663516

Familial Mediterranean fever (recurrent hereditary polyserositis) in children: analysis of 88 cases.

H A Majeed1, M Barakat.   

Abstract

The clinical profile, course and complications of familial Mediterranean fever (recurrent hereditary polyserositis) seen in 88 children over a period of 11 years are presented. Forty eight children (55%) started their illness below the age of 5 years, and the mean age of onset was 4.9 years. Peritonitis occurred in 85% of children, arthritis in 50%, pleuritis in 33% and erysipelas-like lesions in 16%. Two children developed renal amyloidosis, and one third of the children were subjected to unnecessary operative surgery, reflecting the diagnostic difficulties. The arthritis was mono-articular in 80% and polyarticular in 20% of children with arthritis, and was seronegative (rheumatoid factor and antinuclear antibodies). Human leucocyte antigen (HLA) typing for the B-27 antigen carried out in ten children with arthritis was negative. The synovial attack showed a wide variation in the clinical presentation, course and duration of arthritis, causing diagnostic difficulties. The difficulties in the differentiation of recurrent hereditary polyserositis (familial Mediterranean fever) arthritis from the common causes of acute and chronic juvenile arthritis and the seronegative spondyloarthropathies are discussed. Of 45 children treated with colchicine, 42 children (93%) achieved a therapeutic response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663516     DOI: 10.1007/bf00441519

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

1.  [The periodic disease].

Authors:  H MAMOU; R CATTAN
Journal:  Sem Hop       Date:  1952-04-02

2.  Colchicine for familial Mediterranean fever.

Authors:  S E Goldfinger
Journal:  N Engl J Med       Date:  1972-12-21       Impact factor: 91.245

3.  Familial paroxysmal polyserositis. Clinical and laboratory findings in 120 cases.

Authors:  H K Armenian; A K Khachadurian
Journal:  J Med Liban       Date:  1973

Review 4.  Familial Mediterranean fever. A survey of 470 cases and review of the literature.

Authors:  E Sohar; J Gafni; M Pras; H Heller
Journal:  Am J Med       Date:  1967-08       Impact factor: 4.965

5.  Familial Mediterranean fever in an Italian family.

Authors:  C B Reich; E C Franklin
Journal:  Arch Intern Med       Date:  1970-02

6.  Amyloidosis in children with familial Mediterranean fever.

Authors:  A Ludomirsky; J Passwell; H Boichis
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

7.  Familial Hibernian fever.

Authors:  L M Williamson; D Hull; R Mehta; W G Reeves; B H Robinson; P J Toghill
Journal:  Q J Med       Date:  1982

8.  HLA-B27-negative sacroiliitis: a manifestation of familial Mediterranean fever in childhood.

Authors:  T J Lehman; V Hanson; H Kornreich; R S Peters; A D Schwabe
Journal:  Pediatrics       Date:  1978-03       Impact factor: 7.124

9.  A neutrophil lysozyme leak in patients with familial Mediterranean fever.

Authors:  M Bar-Eli; M C Territo; R S Peters; A D Schwabe
Journal:  Am J Hematol       Date:  1981-12       Impact factor: 10.047

10.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; M Modan; S Cabili; J Gafni
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

View more
  12 in total

1.  Familial Mediterranean fever in Syrian children: phenotype-genotype correlation.

Authors:  Rami A Jarjour; Sumaya Al-Berrawi
Journal:  Rheumatol Int       Date:  2014-08-24       Impact factor: 2.631

2.  Cricothyroid arthritis in a child with familial Mediterranean fever.

Authors:  F A Khuffash; H A Majeed
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

Review 3.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

4.  Familial Mediterranean fever in Arab children: the high prevalence and gene frequency.

Authors:  M O Rawashdeh; H A Majeed
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 5.  [Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Kallinich; N Blank; T Braun; E Feist; U Kiltz; U Neudorf; P T Oommen; C Weseloh; H Wittkowski; J Braun
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

6.  Location of the gene causing hyperimmunoglobulinemia D and periodic fever syndrome differs from that for familial Mediterranean fever. International Hyper-IgD Study Group.

Authors:  J P Drenth; E C Mariman; S D Van der Velde-Visser; H H Ropers; J W Van der Meer
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

7.  Can the Thiol/Disulfide Imbalance Be a Predictor of Colchicine Resistance in Familial Mediterranean Fever?

Authors:  Ahmet Omma; Sevinc Can Sandikci; Orhan Kücüksahin; Murat Alisik; Ozcan Erel
Journal:  J Korean Med Sci       Date:  2017-10       Impact factor: 2.153

8.  Familial Mediterranean fever; diagnosis, treatment, and complications.

Authors:  Bahman Bashardoust
Journal:  J Nephropharmacol       Date:  2015-01-01

9.  An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance: Study protocol for investigator-initiated, multicenter, open-label trial.

Authors:  Tomohiro Koga; Naoko Hagimori; Shuntaro Sato; Shinpei Morimoto; Naoki Hosogaya; Chizu Fukushima; Hiroshi Yamamoto; Atsushi Kawakami
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

10.  [Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Sahr; U Kiltz; C Weseloh; T Kallinich; J Braun
Journal:  Z Rheumatol       Date:  2020-09-30       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.